iReprogram

📍 Ann Arbor, United States👥 8 employees💰 Last funded 2024
Biotechnology Research🌐 ireprogram.com
Website LinkedIn
iReprogram is an Ann Arbor, USA based biotech company providing a software platform for direct cell reprogramming. We have assembled an interdisciplinary group of world-renowned researchers, advisors and business partners across biology, mathematics, and computer science, in order to make biology computable. Our novel advanced technology is a patented, data-guided AI-enabled deep learning architecture, creating an in-silico digital twin for cell reprogramming, which predicts key components of next generation therapies for graceful aging, wound healing, cell and tissue replacement, and cancers.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in iReprogram?
iReprogram has 1 investors on record on gritt.io.
When did iReprogram last raise funding?
The most recent investment in iReprogram recorded on gritt.io was in 2024.
What industry is iReprogram in?
iReprogram operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is iReprogram based?
iReprogram is headquartered in Ann Arbor, United States.